Cargando…
Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
Autores principales: | Han, Joseph, Russo, Gerardo, Stratman, Scott, Psomadakis, Corinna E., Rigo, Rachel, Owji, Shayan, Luu, Yen, Mubasher, Adnan, Gonzalez, Belen Rubio, Ungar, Jonathan, Harp, Joanna, Magro, Cynthia, Ungar, Benjamin, Lamb, Angela, Gulati, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077902/ https://www.ncbi.nlm.nih.gov/pubmed/35571457 http://dx.doi.org/10.1016/j.jdcr.2022.04.021 |
Ejemplares similares
-
Elasomeran/terbinafine: Toxic epidermal necrolysis-like linear IgA bullous dermatosis: case report
Publicado: (2022) -
Linear IgA Bullous Dermatosis
por: Chen, Sean, et al.
Publicado: (2013) -
Revisiting the “jelly-roll” technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis
por: Khan, Samavia, et al.
Publicado: (2023) -
Linear IgA bullous dermatosis treated with rituximab
por: Pinard, Camille, et al.
Publicado: (2019) -
Linear IgA and IgG bullous dermatosis
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2016)